Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Legalizing marijuana: What happens if Medicaid starts paying for it?

Doug Farrago, MD
Meds
August 27, 2013
Share
Tweet
Share

Dr. Sanjay Gutpa has come out on the side of medical marijuana.   To him, that is a big deal.  Here is a snippet of what he said:

I apologize because I didn’t look hard enough, until now. I didn’t look far enough. I didn’t review papers from smaller labs in other countries doing some remarkable research, and I was too dismissive of the loud chorus of legitimate patients whose symptoms improved on cannabis.

Instead, I lumped them with the high-visibility malingerers, just looking to get high.

I am all for weed in those legitimate cases, as Dr. Gupta would say.  In Maine, where medical marijuana is legal, I never started prescribing it because of who was coming out of the woodwork.

I did have a great example of a patient, however, with chronic pain and scarring from severe hidradenitis supportiva who was seeing a pain doctor and was on narcs for years.   He negotiated a deal with me to see the “weed doctor” and he started a trial, knowing that I would now test him for narcs.

Long story short, he did great on weed and never took painkillers again.  Great story, right?  Well, I am here to tell you and Dr. Gupta that this is a rarity.  I cannot tell you how many suspect patients who started begging me to get a script.  The law allows them two ounces a week which, as Bill Murray from Caddyshack would say, will allow them enough to “smoke the bejesus out of it” and then share or sell a ton more.

In my opinion, over 90% of the people who asked me for it were people/patients whose intentions I did not trust.  Was I wrong?  That depends:

A recent study by Quest Diagnostics suggests that medical marijuana users are no more likely to misuse prescription drugs such as oxycodone than other patient populations. However, recreational marijuana users are more likely to misuse those drugs. The study, “Prescription Medication Misuse in America,” based on an analysis of 227,402 de-identified urine lab-test results of patients on commonly abused prescription medications, shows that 37 percent of medical marijuana users (those taking prescribed cannabinoids as pharmaceutical preparations) misused other non-prescribed drugs, while nearly half of patients who used marijuana recreationally misused prescription medications.

First of all, it is crazy to me that 37% of medical marijuana users are misusing other non-prescribed drugs and this is felt to be equal to the normal population.  But let’s take this study at face value.   My first patient who I described above truly needed weed and was someone I could trust and the study supports that.

The other patients, who I thought were just looking to get a legal excuse to smoke weed, I could not.   They were already recreational users and probably abusing other drugs as well.  I guess the study proves my point.   It is about trust just like when we prescribe narcotics.

So, to summarize, I support medical marijuana but I am not pollyanna about it.  Just because Dr. Gupta had some epiphany about cannibis doesn’t mean there aren’t those out there ready to abuse the hell out of it.  I will stick to my 90% statement.

Now before people get on my case about being a hardass or why not just let them have it or weed never kills anyone and on and on, let me remind you of the next debacle that will occur once you open these flood gates.  Right now, Medicaid isn’t paying for it (and for some funny reason these patients now have cash for it) but there will be a movement to change this.

Lawyers will eventually get this overturned and that is when the fun begins. Then the 90% will turn to 99% because it will be a great new source of income for a ton of people as they sell what they supposedly medically need.  Not only will our taxes be paying for suspect people to use the drug but it will pay for their supply to sell it on the streets.  And this will not change it if is legalized for non-medical use either, by the way, because these same patients will want it for free via a prescription (think about the times they ask for Tylenol scripts).

ADVERTISEMENT

You may think, so what, we do this already for narcotics.  And I would say, exactly.

Doug Farrago is a family physician who blogs at Authentic Medicine.

Prev

Independent doctors: Update your shingle for today's digital times

August 27, 2013 Kevin 4
…
Next

Seeking an end to the prostate cancer and finasteride discussion

August 27, 2013 Kevin 1
…

Tagged as: Primary Care

Post navigation

< Previous Post
Independent doctors: Update your shingle for today's digital times
Next Post >
Seeking an end to the prostate cancer and finasteride discussion

ADVERTISEMENT

More by Doug Farrago, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Don’t take the damn EMR into the exam room

    Doug Farrago, MD
  • a desk with keyboard and ipad with the kevinmd logo

    We shouldn’t need the permission of administrators to heal ourselves

    Doug Farrago, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Medical homes: Taking what an insurer says at face value

    Doug Farrago, MD

More in Meds

  • Oral Wegovy: the miracle and the mess of the new GLP-1 pill

    Shiv K. Goel, MD
  • U.S. opioid policy history: How politics replaced science in pain care

    Richard A. Lawhern, PhD & Stephen E. Nadeau, MD
  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Most Popular

  • Past Week

    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • The gastroenterologist shortage: Why supply is falling behind demand

      Brian Hudes, MD | Physician
    • Health care as a human right vs. commodity: Resolving the paradox

      Timothy Lesaca, MD | Physician
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Why voicemail in outpatient care is failing patients and staff

      Dan Ouellet | Tech
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Remote second opinions bridge the gap in rural cancer survival [PODCAST]

      The Podcast by KevinMD | Podcast
    • High-protein diet risks: Why more isn’t always better

      Farid Sabet-Sharghi, MD | Conditions
    • Breaking the silence: mental health and racism in medical school

      Michael F. Myers, MD | Physician
    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • Why AI in health care is the only fix for physician shortages

      John C. Hagan III, MD | Physician
    • Health insurance waste: Why eliminating the middleman saves billions

      Edward Anselm, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 17 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • The hidden costs of the physician non-clinical career transition

      Carlos N. Hernandez-Torres, MD | Physician
    • The gastroenterologist shortage: Why supply is falling behind demand

      Brian Hudes, MD | Physician
    • Health care as a human right vs. commodity: Resolving the paradox

      Timothy Lesaca, MD | Physician
    • Why private equity is betting on employer DPC over retail

      Dana Y. Lujan, MBA | Policy
    • Why voicemail in outpatient care is failing patients and staff

      Dan Ouellet | Tech
  • Past 6 Months

    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
  • Recent Posts

    • Remote second opinions bridge the gap in rural cancer survival [PODCAST]

      The Podcast by KevinMD | Podcast
    • High-protein diet risks: Why more isn’t always better

      Farid Sabet-Sharghi, MD | Conditions
    • Breaking the silence: mental health and racism in medical school

      Michael F. Myers, MD | Physician
    • My wife’s story: How DEA and CDC guidelines destroyed our golden years

      Monty Goddard & Richard A. Lawhern, PhD | Conditions
    • Why AI in health care is the only fix for physician shortages

      John C. Hagan III, MD | Physician
    • Health insurance waste: Why eliminating the middleman saves billions

      Edward Anselm, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Legalizing marijuana: What happens if Medicaid starts paying for it?
17 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...